Drug Shortage Report for BEPREVE

Last updated on 2020-02-14 History
Report ID 103041
Drug Identification Number 02456532
Brand name BEPREVE
Common or Proper name BEPREVE
Company Name BAUSCH & LOMB INC
Market Status MARKETED
Active Ingredient(s) BEPOTASTINE BESILATE
Strength(s) 1.5%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 10ml
ATC code S01
ATC description L3 not assigned
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-15
Estimated end date
Actual end date 2020-02-11
Shortage status Resolved
Updated date 2020-02-14
Company comments artwork issue
Health Canada comments
Contact Address 1400 N GOODMAN STREET
ROCHESTER, NEW YORK
UNITED STATES 14609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-10 English Compare
v2 2020-01-10 French Compare
v3 2020-02-14 English Compare
v4 2020-02-14 French Compare